Do pathogen exposure and innate immunity cause brain diseases? (Q36273698)

13 August 2017

1 reference

title

Do pathogen exposure and innate immunity cause brain diseases? (English)

1 reference

13 August 2017

Alain R Simard

1

1 reference

13 August 2017

Serge Rivest

series ordinal

2

1 reference

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

13 August 2017

published in

Neurological Research

1 reference

13 August 2017

volume

27

1 reference

13 August 2017

issue

7

1 reference

13 August 2017

page(s)

717-725

1 reference

Toll signaling pathways in the innate immune response

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Toll, a new piece in the puzzle of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Structure and function of lipopolysaccharide binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Immunology. After the toll rush

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

How we detect microbes and respond to them: the Toll-like receptors and their transducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Recognition of microbial infection by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

A toll-like receptor that prevents infection by uropathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Triggering the interferon antiviral response through an IKK-related pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Innate immunity: the missing link in neuroprotection and neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Is survival possible without arachidonate metabolites in the brain during systemic infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Glucocorticoids: protectors of the brain during innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Interleukin-1β protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

Role of inflammation in the neurobiology of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49526

21 January 2018

Identifiers

DOI

10.1179/016164105X49526

1 reference

13 August 2017

1 reference